Impact of body mass index on treatment and outcomes in patients with early hormone receptor-positive breast cancer receiving endocrine therapy with or without palbociclib in the PALLAS trial.
- Citation:
- J Clin Oncol vol 40 (16_suppl) 518-518
- Meeting Instance:
- ASCO 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- AFT
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3905
- Pharmas:
- Pfizer
- Grants:
- Corr. Author:
- Authors:
- Georg Pfeiler Dominik Hlauschek Erica L Mayer Christine Deutschmann Stephanie Kacerovski-Strobl Miguel Martin Jane Meisel Nicholas Zdenkowski Sybille Loibl Marija Balic Heaseong Park Aleix Prat Claudine Isaacs Jana Machacek-Link Céline Schurmans Christian Fesl Amylou Dueck Angela DeMichele Michael Gnant
- Networks:
- CAPITAL, LAPS-MA036, LAPS-MN026, LAPS-PA015
- Study
- AFT-05
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: